Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Conditions: Acute Leukemia of Ambiguous Lineage; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm; Hematopoietic and Lymphoid System Neoplasm; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome; Myeloproliferati ve Neoplasm; Non-Hodgkin Lymphoma Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspirate; Drug: Cyclophosphamide; Drug: Cyclosporine; Procedure: Diagnostic Imaging; Procedure: Echocardiography; Drug: Fludarabine Phosphate; Procedure: Multigated Acquisition Scan; Drug: Mycopheno late Mofetil; Other: Survey Administration; Drug: Thiotepa; Radiation: Total-Body Irradiation; Procedure: Umbilical Cord Blood Transplantation Sponsors: Fred Hutchinson Cancer Center; National Cord Blood Network Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Hematology | Leukemia | Lymphoma | Mergers and Aquisitions | PET Scan | Research | Restasis | Transplants